Immunoassay is a test conducted to determine concentration of macromolecule in a solution using antibody or immunoglobulin. The macromolecule detected is known as analyte. Immunoassay is used to measure quantity of analytes in serum and urine for medical and research purposes. It is also used in qualitative, quantitative and radioactivity procedures to ensure accuracy of results obtained. High sensitivity and specificity of immunoassays are used to speed up the reactions.
Rising incidences of chronic & infectious disease and use of immunoassays in Oncology are factor propelling the growth of the world immunoassay market. In addition, technological advancements and sensitivity, cost effectiveness, & rapid analysis offered by immunoassays supplement the growth. However, low detection limit and implementation of excise duty by the U.S. Government are hindering the growth of this market. Expanding biotechnology & pharmaceutical industries and laboratory automation and emerging markets in Asia presents significant opportunities.
The world immunoassay market is segmented based on technology, product & services, application, end user, and geography. The technology segment is further classified into ELISA, fluorescence, colorimetric, chemiluminescence, rapid test, western blot, ELISPOT, and PCR. The products & services covered in the report are reagents & kits, analyzers, and software services. The applications discussed in the report are infectious disease, endocrinology, cardiology, oncology, and hematology. The end user segment is further classified into hospitals, clinical laboratories, blood banks, academic research centers, pharmaceutical companies, and biotechnology companies, and others. Worldly, the market is segmented into North America, Asia, Europe, and Latin America, Middle East and Africa (LAMEA).
The prominent manufacturers operating in the market are Roche Diagnostics Limited, Siemens Healthcare, Abbott Laboratories, Beckman Coulter, Ortho Clinical Diagnostics, BioMrieux, Bio-Rad Laboratories Inc., Alere Inc., Sysmex Corporation, and Becton, Dickinson & Company. Various strategies, such as expansions, collaborations, partnerships, mergers & acquisitions, expansions, joint ventures, and others have been adopted by prominent manufacturers to gain a strong foothold in the market.
KEY BENEFITS FOR STAKEHOLDERS:
The report offers an in-depth analysis of key driving and restraining factors of the world immunoassay market.
This report offers an in-depth quantitative analysis of the current market and estimations through 2015 and 2020, which assists in identifying the prevailing market opportunities.
The report provides an extensive analysis of current and future market status of the world immunoassay market.
An in-depth analysis of key strategies adopted by leading manufacturers helps in understanding competitive scenario.
An in-depth analysis of current research and clinical developments within the world immunoassay market is provided with key market dynamic factors that helps in understanding the behaviour of the market.
Competitive intelligence (of leading manufacturers and distributors of immunoassay) helps in understanding the competitive scenario across geographies.
Geographically, the world immunoassay market is segmented into North America, Asia, Europe, and Latin America, Middle East and Africa (LAMEA).
KEY MARKET SEGMENTS:
The Immunoassay Market By Technology
ELISA
Fluorescence
Colorimetric
Chemiluminescence
Rapid Test
Western Blot
ELISPOT
PCR
The Immunoassay Market By Product & Service
Reagents & Kits
Analyzers
Software Services
The Immunoassay Market By Application
Infectious Disease
Endocrinology
Cardiology
Oncology
Hematology
The Immunoassay Market By End User
Hospitals
Clinical Laboratories
Blood Banks
Academic Research Centers
Pharmaceutical Companies
Biotechnology Companies
Others
The Immunoassay Market By Geography
North America
Asia
Rising incidences of chronic & infectious disease and use of immunoassays in Oncology are factor propelling the growth of the world immunoassay market. In addition, technological advancements and sensitivity, cost effectiveness, & rapid analysis offered by immunoassays supplement the growth. However, low detection limit and implementation of excise duty by the U.S. Government are hindering the growth of this market. Expanding biotechnology & pharmaceutical industries and laboratory automation and emerging markets in Asia presents significant opportunities.
The world immunoassay market is segmented based on technology, product & services, application, end user, and geography. The technology segment is further classified into ELISA, fluorescence, colorimetric, chemiluminescence, rapid test, western blot, ELISPOT, and PCR. The products & services covered in the report are reagents & kits, analyzers, and software services. The applications discussed in the report are infectious disease, endocrinology, cardiology, oncology, and hematology. The end user segment is further classified into hospitals, clinical laboratories, blood banks, academic research centers, pharmaceutical companies, and biotechnology companies, and others. Worldly, the market is segmented into North America, Asia, Europe, and Latin America, Middle East and Africa (LAMEA).
The prominent manufacturers operating in the market are Roche Diagnostics Limited, Siemens Healthcare, Abbott Laboratories, Beckman Coulter, Ortho Clinical Diagnostics, BioMrieux, Bio-Rad Laboratories Inc., Alere Inc., Sysmex Corporation, and Becton, Dickinson & Company. Various strategies, such as expansions, collaborations, partnerships, mergers & acquisitions, expansions, joint ventures, and others have been adopted by prominent manufacturers to gain a strong foothold in the market.
KEY BENEFITS FOR STAKEHOLDERS:
The report offers an in-depth analysis of key driving and restraining factors of the world immunoassay market.
This report offers an in-depth quantitative analysis of the current market and estimations through 2015 and 2020, which assists in identifying the prevailing market opportunities.
The report provides an extensive analysis of current and future market status of the world immunoassay market.
An in-depth analysis of key strategies adopted by leading manufacturers helps in understanding competitive scenario.
An in-depth analysis of current research and clinical developments within the world immunoassay market is provided with key market dynamic factors that helps in understanding the behaviour of the market.
Competitive intelligence (of leading manufacturers and distributors of immunoassay) helps in understanding the competitive scenario across geographies.
Geographically, the world immunoassay market is segmented into North America, Asia, Europe, and Latin America, Middle East and Africa (LAMEA).
KEY MARKET SEGMENTS:
The Immunoassay Market By Technology
ELISA
Fluorescence
Colorimetric
Chemiluminescence
Rapid Test
Western Blot
ELISPOT
PCR
The Immunoassay Market By Product & Service
Reagents & Kits
Analyzers
Software Services
The Immunoassay Market By Application
Infectious Disease
Endocrinology
Cardiology
Oncology
Hematology
The Immunoassay Market By End User
Hospitals
Clinical Laboratories
Blood Banks
Academic Research Centers
Pharmaceutical Companies
Biotechnology Companies
Others
The Immunoassay Market By Geography
North America
Asia
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
